Markets:

Overview

News

Currencies

International

Treasuries

Evolus, Inc. - Common Stock (NQ:EOLS)

6.270 -0.250 (-3.83%)

Streaming Delayed Price Updated: 11:07 AM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evolus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 08, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.

Via Benzinga

Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday ↗

November 08, 2023

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Earnings Preview: Evolus ↗

August 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 08, 2023

Via Benzinga

Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

November 08, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 07, 2023

Via Benzinga

Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®

November 07, 2023

From Evolus

Via Business Wire

5 Analysts Have This to Say About Evolus ↗

July 28, 2023

Via Benzinga

Evolus Inc. (NASDAQ: EOLS) Highlighted for Surprising Price Action

July 27, 2023

Via Investor Brand Network

Why Shares of Evolus Are Jumping Thursday ↗

July 27, 2023

The stock climbed on record second-quarter revenue and a raise in full-year guidance.

Via The Motley Fool

“Extra-Strength” 40U Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting

November 06, 2023

From Evolus

Via Business Wire

Evolus to Participate in November Investor Conferences

November 01, 2023

From Evolus

Via Business Wire

Evolus to Report Third Quarter 2023 Results

October 25, 2023

From Evolus

Via Business Wire

Final Phase 2 Data Evaluating 40U Dose of PrabotulinumtoxinA-xvfs to be Presented at 2023 ASDS Annual Meeting

October 25, 2023

From Evolus

Via Business Wire

7 Must-Own Small-Cap Stocks That Could Outperform the Market ↗

October 08, 2023

If you’re ready to absorb significant risk for the chance of ridiculous upside, these small-cap stocks to buy may be just for you.

Via InvestorPlace

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 29, 2023

From Evolus

Via Business Wire

7 Small-Cap Stocks Analysts Predict Will Double in 2024 ↗

September 13, 2023

While small-cap stocks to buy present exceptional risk, they also offer tremendous rewards for intrepid retail investors.

Via InvestorPlace

Evolus to Participate in September Conferences

August 29, 2023

From Evolus

Via Business Wire

Evolus Announces Inducement Grants for New Chief Marketing Officer

August 23, 2023

From Evolus

Via Business Wire

Evolus Appoints Tomoko Yamagishi-Dressler as Chief Marketing Officer

August 21, 2023

From Evolus

Via Business Wire

Over $15M Bet On Impinj? Check Out These 4 Stocks Insiders Are Buying ↗

August 16, 2023

Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.

Via Benzinga

Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline

August 08, 2023

Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...

Via Newsfile

Evolus Unveils New Branding for Flagship Product Jeuveau® to Reflect Growing and Evolving Consumers

August 08, 2023

From Evolus

Via Business Wire

Evolus Reports Second Quarter 2023 Results and Provides Business Update

August 02, 2023

From Evolus

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 27, 2023

Via Benzinga

Comcast, STMicroelectronics, Lam Research, Meta Platforms And Other Big Stocks Moving Higher On Thursday ↗

July 27, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 27, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Via Benzinga

Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue

July 27, 2023

From Evolus

Via Business Wire

Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference

July 26, 2023

From Evolus, Inc.

Via Business Wire

Evolus to Report Second Quarter 2023 Results and Provide Business Update

July 19, 2023

From Evolus

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.